X0704 D/A LIVE 0001426332 NGM BIOPHARMACEUTICALS INC 630 Gateway Boulevard South San Francisco CA CALIFORNIA 94080 650-243-5555 DELAWARE None None Corporation true 2007 Jin-Long Chen c/o NGM Biopharmaceuticals, Inc. 630 Gateway Boulevard South San Francisco CA CALIFORNIA 94080 Executive Officer Director Luis Bayol c/o NGM Biopharmaceuticals, Inc. 630 Gateway Boulevard South San Francisco CA CALIFORNIA 94080 Executive Officer David V. Goeddel c/o NGM Biopharmaceuticals, Inc. 630 Gateway Boulevard South San Francisco CA CALIFORNIA 94080 Executive Officer Director Helen Kim c/o NGM Biopharmaceuticals, Inc. 630 Gateway Boulevard South San Francisco CA CALIFORNIA 94080 Executive Officer Marc Leschly c/o Rho Ventures 525 University Ave., Suite 1350 Palo Alto CA CALIFORNIA 94301 Director Arthur D. Levinson c/o NGM Biopharmaceuticals, Inc. 630 Gateway Boulevard South San Francisco CA CALIFORNIA 94080 Director David Schnell c/o Prospect Ventures, L.P. 435 Tasso St., Suite 200 Palo Alto CA CALIFORNIA 94301 Director Peter Svennilson 3121 Polo Drive Gulf Stream FL FLORIDA 33483 Director McHenry T. Tichenor, Jr. c/o Tichenor Ventures, LLC 100 Crescent Court, Suite 700 Dallas TX TEXAS 75201 Director Biotechnology Decline to Disclose 06 true 0001426332-10-000001 2010-03-10 true true true Sale and issuance of Series B preferrred stock and the underlying shares of common stock issuable upon conversion thereof. false 0 55664000 21529670 34134330 false 20 0 0 0 false NGM BIOPHARMACEUTICALS INC Michael E. Tenta Michael E. Tenta Assistant Secretary 2010-04-26